Vicarious Surgical Schedules Special Meeting to Vote on Reverse Stock Split for Nasdaq Relisting Bid

summarizeSummary

Vicarious Surgical filed a definitive proxy statement for a special meeting on April 8, 2026, to vote on a reverse stock split (1-for-2 to 1-for-30) to meet Nasdaq listing requirements after its NYSE delisting.

check_boxKey Events

• Shareholder Meeting Scheduled

  A special meeting of stockholders is set for April 8, 2026, to vote on the proposed reverse stock split.

• Reverse Stock Split Proposal

  Shareholders will vote on an amendment to the Certificate of Incorporation to effect a reverse stock split at a ratio between 1-for-2 and 1-for-30, with the exact ratio to be determined by the Board.

• Purpose: Nasdaq Relisting Bid

  The primary goal of the reverse split is to increase the per-share price to meet the $4.00 minimum bid price requirement for listing on the Nasdaq Capital Market, following the company's delisting from the NYSE.

• Board Discretion

  The Board of Directors retains the sole discretion to determine the exact ratio within the approved range and can choose to abandon the reverse stock split even if approved by shareholders.

auto_awesomeAnalysis

This definitive proxy statement outlines the company's plan to seek shareholder approval for a reverse stock split, ranging from 1-for-2 to 1-for-30. This action is a critical response to the company's recent NYSE delisting and its current trading on the OTCID market, aiming to increase the per-share price to meet Nasdaq Capital Market listing requirements. The proposal is a necessary step for Vicarious Surgical, which recently disclosed substantial doubt about its ability to continue as a going concern, to potentially regain exchange listing and improve investor confidence and liquidity.